The DOI matches its Crossref record; 151 of the 151 references it cites were found in a registry or an index.
Antimicrobial resistance of Pseudomonas aeruginosa: navigating clinical impacts, current resistance trends, and innovations in breaking therapies
Open accessAbstract
Pseudomonas aeruginosa, a Gram-negative bacterium, is recognized for its adaptability and opportunistic nature. It poses a substantial challenge in clinical settings due to its complicated antibiotic resistance mechanisms, biofilm formation, and capacity for persistent infections in both animal and human hosts. Recent studies revealed a potential zoonotic transmission of P. aeruginosa between animals, the environment, and human populations which highlights awareness of this microbe. Implementation of the One Health approach, which underscores the connection between human, animal, and environmental health, we aim to offer a comprehensive perspective on the current landscape of P. aeruginosa management. This review presents innovative strategies designed to counteract P. aeruginosa infections. Traditional antibiotics, while effective in many cases, are increasingly compromised by the development of multidrug-resistant strains. Non-antibiotic avenues, such as quorum sensing inhibition, phage therapy, and nanoparticle-based treatments, are emerging as promising alternatives. However, their clinical application encounters obstacles like cost, side effects, and safety concerns. Effectively addressing P. aeruginosa infections necessitates persistent research efforts, advancements in clinical development, and a comprehension of host-pathogen interactions to deal with this resilient pathogen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
Murray, C. J. L., Ikuta, K. S., Sharara, F., Swetschinski, L., Robles Aguilar, G., Gray, A., Han, C., Bisignano, C., Rao, P., Wool, E., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)02724-0 · Cited by 16,316 · cited 1×
“Bacteremia caused by P. aeruginosa carries a poor prognosis, rapidly progressive course, and high mortality rate (Murray et al., 2022).”
BackgroundMagiorakos, A.-P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G., Olsson-Liljequist, B., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03570.x · Cited by 14,449
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies
Pang, Z., Raudonis, R., Glick, B. R., Lin, T.-J., & Cheng, Z. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.11.013 · Cited by 2,306
Qin, S., Xiao, W., Zhou, C., Pu, Q., Deng, X., Lan, L., Liang, H., Song, X., & Wu, M. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01056-1 · Cited by 1,703
Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review
Mulani, M. S., Kamble, E. E., Kumkar, S. N., Tawre, M. S., & Pardesi, K. R. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00539 · Cited by 1,644
Antibiotics versus biofilm: an emerging battleground in microbial communities
Sharma, D., Misba, L., & Khan, A. U. (2019) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-019-0533-3 · Cited by 1,553
Pseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence
Moradali, M. F., Ghods, S., & Rehm, B. H. A. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00039 · Cited by 1,537
Roy, R., Tiwari, M., Donelli, G., & Tiwari, V. (2018) · Virulence · doi:10.1080/21505594.2017.1313372 · Cited by 1,523
Aminoglycoside modifying enzymes
Ramirez, M. S., & Tolmasky, M. E. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.08.003 · Cited by 1,464
β-Lactams and β-Lactamase Inhibitors: An Overview
Bush, K., & Bradford, P. A. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025247 · Cited by 1,412
Overview of Nosocomial Infections Caused by Gram-Negative Bacilli
Weinstein, R. A., Gaynes, R., Edwards, J. R., & System, N. N. I. S. (2005) · Clinical Infectious Diseases · doi:10.1086/432803 · Cited by 1,404 · cited 1×
“(Gaynes and Edwards, 2005).”
Establishment of infection: lessons from a versatile opportunist
Lyczak, J. B., Cannon, C. L., & Pier, G. B. (2000) · Microbes and Infection · doi:10.1016/s1286-4579(00)01259-4 · Cited by 1,341
Krause, K. M., Serio, A. W., Kane, T. R., & Connolly, L. E. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a027029 · Cited by 1,149
Bacterial Biofilm and its Role in the Pathogenesis of Disease
Vestby, L. K., Grønseth, T., Simm, R., & Nesse, L. L. (2020) · Antibiotics · doi:10.3390/antibiotics9020059 · Cited by 1,105
β-Lactamases and β-Lactamase Inhibitors in the 21st Century
Tooke, C. L., Hinchliffe, P., Bragginton, E. C., Colenso, C. K., Hirvonen, V. H. A., Takebayashi, Y., & Spencer, J. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.04.002 · Cited by 1,016
Prevalence and outcomes of infection among patients in intensive care units in 2017.
Vincent, J.-L., Sakr, Y., Singer, M., Martin-Loeches, I., Machado, F. R., Marshall, J. C., Finfer, S., Pelosi, P., Brazzi, L., Aditianingsih, D., et al. (2020) · JAMA · doi:10.1001/jama.2020.2717 · Cited by 1,011
Sharma, S., Mohler, J., Mahajan, S. D., Schwartz, S. A., Bruggemann, L., & Aalinkeel, R. (2023) · Microorganisms · doi:10.3390/microorganisms11061614 · Cited by 993
Horcajada, J. P., Montero, M., Oliver, A., Sorlí, L., Luque, S., Gómez-Zorrilla, S., Benito, N., & Grau, S. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00031-19 · Cited by 961
Pseudomonas Aeruginosa: Resistance to the Max
Poole, K. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00065 · Cited by 948
Bacterial Extracellular Polysaccharides in Biofilm Formation and Function
Limoli, D. H., Jones, C. J., & Wozniak, D. J. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mb-0011-2014 · Cited by 924
Wagner, V. E., Bushnell, D., Passador, L., Brooks, A. I., & Iglewski, B. H. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.7.2080-2095.2003 · Cited by 920
Pseudomonas aeruginosa Biofilms
Thi, M. T. T., Wibowo, D., & Rehm, B. H. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228671 · Cited by 911
Beyond Risk: Bacterial Biofilms and Their Regulating Approaches
Muhammad, M. H., Idris, A. L., Fan, X., Guo, Y., Yu, Y., Jin, X., Qiu, J., Guan, X., & Huang, T. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00928 · Cited by 860
Antimicrobials and Antibiotic-Resistant Bacteria: A Risk to the Environment and to Public Health
Serwecińska, L. (2020) · Water · doi:10.3390/w12123313 · Cited by 842
Extended-spectrum β-lactamases: an update on their characteristics, epidemiology and detection
Castanheira, M., Simner, P. J., & Bradford, P. A. (2021) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlab092 · Cited by 796
The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update
Reynolds, D., & Kollef, M. (2021) · Drugs · doi:10.1007/s40265-021-01635-6 · Cited by 721
Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa
Chan, B. K., Sistrom, M., Wertz, J. E., Kortright, K. E., Narayan, D., & Turner, P. E. (2016) · Scientific Reports · doi:10.1038/srep26717 · Cited by 715
Pseudomonas aeruginosa: An Audacious Pathogen with an Adaptable Arsenal of Virulence Factors
Jurado-Martín, I., Sainz-Mejías, M., & McClean, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063128 · Cited by 698
Understanding the Mechanism of Bacterial Biofilms Resistance to Antimicrobial Agents
Singh, S., Singh, S. K., Chowdhury, I., & Singh, R. (2017) · The Open Microbiology Journal · doi:10.2174/1874285801711010053 · Cited by 697
Potron, A., Poirel, L., & Nordmann, P. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.03.001 · Cited by 688
Cho, H., Uehara, T., & Bernhardt, T. G. (2014) · Cell · doi:10.1016/j.cell.2014.11.017 · Cited by 642
Emergence of antibiotic resistance Pseudomonas aeruginosa in intensive care unit; a critical review
Pachori, P., Gothalwal, R., & Gandhi, P. (2019) · Genes & Diseases · doi:10.1016/j.gendis.2019.04.001 · Cited by 620
Colvin, K. M., Irie, Y., Tart, C. S., Urbano, R., Whitney, J. C., Ryder, C., Howell, P. L., Wozniak, D. J., & Parsek, M. R. (2012) · Environmental Microbiology · doi:10.1111/j.1462-2920.2011.02657.x · Cited by 612
Horizontal Gene Transfer of Antibiotic Resistance Genes in Biofilms
Michaelis, C., & Grohmann, E. (2023) · Antibiotics · doi:10.3390/antibiotics12020328 · Cited by 612
The pyocins of Pseudomonas aeruginosa
Michel-Briand, Y., & Baysse, C. (2002) · Biochimie · doi:10.1016/s0300-9084(02)01422-0 · Cited by 560
Topoisomerase Inhibitors: Fluoroquinolone Mechanisms of Action and Resistance
Hooper, D. C., & Jacoby, G. A. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025320 · Cited by 553
Regulation of quorum sensing in Pseudomonas
Venturi, V. (2006) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2005.00012.x · Cited by 540
Curran, B., Jonas, D., Grundmann, H., Pitt, T., & Dowson, C. G. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.12.5644-5649.2004 · Cited by 509
Cellular Effects of Pyocyanin, a Secreted Virulence Factor of Pseudomonas aeruginosa
Hall, S., McDermott, C., Anoopkumar-Dukie, S., McFarland, A., Forbes, A., Perkins, A., Davey, A., Chess-Williams, R., Kiefel, M., Arora, D., et al. (2016) · Toxins · doi:10.3390/toxins8080236 · Cited by 421
Pseudomonas aeruginosa Biofilms: Host Response and Clinical Implications in Lung Infections
Maurice, N. M., Bedi, B., & Sadikot, R. T. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0321tr · Cited by 373
del Barrio-Tofiño, E., López-Causapé, C., & Oliver, A. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106196 · Cited by 372
Biofilm Matrix and Its Regulation in Pseudomonas aeruginosa
Wei, Q., & Ma, L. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141020983 · Cited by 369
Fu, W., Forster, T., Mayer, O., Curtin, J. J., Lehman, S. M., & Donlan, R. M. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00669-09 · Cited by 362
Role of Efflux Pumps on Antimicrobial Resistance in Pseudomonas aeruginosa
Lorusso, A. B., Carrara, J. A., Barroso, C. D. N., Tuon, F. F., & Faoro, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415779 · Cited by 347
Rosenthal, V. D., Al-Abdely, H. M., El-Kholy, A. A., AlKhawaja, S. A. A., Leblebicioglu, H., Mehta, Y., Rai, V., Hung, N. V., Kanj, S. S., Salama, M. F., et al. (2016) · American Journal of Infection Control · doi:10.1016/j.ajic.2016.08.007 · Cited by 335
Filamentous Bacteriophage Promote Biofilm Assembly and Function
Secor, P. R., Sweere, J. M., Michaels, L. A., Malkovskiy, A. V., Lazzareschi, D., Katznelson, E., Rajadas, J., Birnbaum, M. E., Arrigoni, A., Braun, K. R., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.10.013 · Cited by 331
Paczkowski, J. E., Mukherjee, S., McCready, A. R., Cong, J.-P., Aquino, C. J., Kim, H., Henke, B. R., Smith, C. D., & Bassler, B. L. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.770552 · Cited by 319
β-Lactam Resistance Response Triggered by Inactivation of a Nonessential Penicillin-Binding Protein
Moya, B., Dötsch, A., Juan, C., Blázquez, J., Zamorano, L., Haussler, S., & Oliver, A. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000353 · Cited by 287
Pseudomonas aeruginosa biofilms: role of the alginate exopolysaccharide
Boyd, A., & Chakrabarty, A. M. (1995) · Journal of Industrial Microbiology · doi:10.1007/bf01569821 · Cited by 286
The strange history of phage therapy
Summers, W. C. (2012) · Bacteriophage · doi:10.4161/bact.20757 · Cited by 284
Bacterial Multidrug Efflux Pumps at the Frontline of Antimicrobial Resistance: An Overview
Huang, L., Wu, C., Gao, H., Xu, C., Dai, M., Huang, L., Hao, H., Wang, X., & Cheng, G. (2022) · Antibiotics · doi:10.3390/antibiotics11040520 · Cited by 284
Pseudomonas Exotoxin A: optimized by evolution for effective killing
Michalska, M., & Wolf, P. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00963 · Cited by 283
Sousa, A., & Pereira, M. (2014) · Pathogens · doi:10.3390/pathogens3030680 · Cited by 279
Haidar, G., Philips, N. J., Shields, R. K., Snyder, D., Cheng, S., Potoski, B. A., Doi, Y., Hao, B., Press, E. G., Cooper, V. S., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix182 · Cited by 277
Pathogenesis of Gram-Negative Bacteremia
Holmes, C. L., Anderson, M. T., Mobley, H. L. T., & Bachman, M. A. (2021) · Clinical Microbiology Reviews · doi:10.1128/cmr.00234-20 · Cited by 277
How to Enter a Bacterium: Bacterial Porins and the Permeation of Antibiotics
Prajapati, J. D., Kleinekathöfer, U., & Winterhalter, M. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01213 · Cited by 271
The Advantages and Challenges of Using Endolysins in a Clinical Setting
Murray, E., Draper, L. A., Ross, R. P., & Hill, C. (2021) · Viruses · doi:10.3390/v13040680 · Cited by 263
Pseudomonas aeruginosa: Infections, Animal Modeling, and Therapeutics
Wood, S. J., Kuzel, T. M., & Shafikhani, S. H. (2023) · Cells · doi:10.3390/cells12010199 · Cited by 254
Langendonk, R. F., Neill, D. R., & Fothergill, J. L. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.665759 · Cited by 250
Key two‐component regulatory systems that control biofilm formation in Pseudomonas aeruginosa
Mikkelsen, H., Sivaneson, M., & Filloux, A. (2011) · Environmental Microbiology · doi:10.1111/j.1462-2920.2011.02495.x · Cited by 242
Pena, C., Cabot, G., Gomez-Zorrilla, S., Zamorano, L., Ocampo-Sosa, A., Murillas, J., Almirante, B., Pomar, V., Aguilar, M., Granados, A., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu866 · Cited by 216
Phage therapy is highly effective against chronic lung infections with Pseudomonas aeruginosa
Waters, E. M., Neill, D. R., Kaman, B., Sahota, J. S., Clokie, M. R. J., Winstanley, C., & Kadioglu, A. (2017) · Thorax · doi:10.1136/thoraxjnl-2016-209265 · Cited by 212
Lesic, B., Starkey, M., He, J., Hazan, R., & Rahme, L. G. (2009) · Microbiology · doi:10.1099/mic.0.029082-0 · Cited by 209
Toxicological status of nanoparticles: What we know and what we don't know
Missaoui, W. N., Arnold, R. D., & Cummings, B. S. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.07.015 · Cited by 191
A Novel Antimicrobial Endolysin, LysPA26, against Pseudomonas aeruginosa
Guo, M., Feng, C., Ren, J., Zhuang, X., Zhang, Y., Zhu, Y., Dong, K., He, P., Guo, X., & Qin, J. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00293 · Cited by 190
Interaction of antibacterial compounds with RND efflux pumps in Pseudomonas aeruginosa
Dreier, J., & Ruggerone, P. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00660 · Cited by 189
Therapy of Experimental Pseudomonas Infections with a Nonreplicating Genetically Modified Phage
Hagens, S., Habel, A., von Ahsen, U., von Gabain, A., & Bläsi, U. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3817-3822.2004 · Cited by 187
Phage Therapy: a Step Forward in the Treatment of Pseudomonas aeruginosa Infections
Pires, D. P., Vilas Boas, D., Sillankorva, S., & Azeredo, J. (2015) · Journal of Virology · doi:10.1128/jvi.00385-15 · Cited by 185
Integrons in the development of antimicrobial resistance: critical review and perspectives
Bhat, B. A., Mir, R. A., Qadri, H., Dhiman, R., Almilaibary, A., Alkhanani, M., & Mir, M. A. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1231938 · Cited by 183
Pai, S., Hebbar, A., & Selvaraj, S. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-022-19423-4 · Cited by 178
Riera, E., Cabot, G., Mulet, X., Garcia-Castillo, M., del Campo, R., Juan, C., Canton, R., & Oliver, A. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr232 · Cited by 175
Pseudomonas Skin Infection: Clinical Features, Epidemiology, and Management
Wu, D. C., Chan, W. W., Metelitsa, A. I., Fiorillo, L., & Lin, A. N. (2011) · American Journal of Clinical Dermatology · doi:10.2165/11539770-000000000-00000 · Cited by 164
Bassetti, M., Castaldo, N., Cattelan, A., Mussini, C., Righi, E., Tascini, C., Menichetti, F., Mastroianni, C. M., Tumbarello, M., Grossi, P., et al. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.11.001 · Cited by 162
Impact of Pseudomonas aeruginosa Infection on Patients with Chronic Inflammatory Airway Diseases
Garcia-Clemente, M., de la Rosa, D., Máiz, L., Girón, R., Blanco, M., Olveira, C., Canton, R., & Martinez-García, M. A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123800 · Cited by 160
Bacteriophage-derived endolysins to target gram-negative bacteria
Lai, W. C. B., Chen, X., Ho, M. K. Y., Xia, J., & Leung, S. S. Y. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119833 · Cited by 147
Grosso-Becerra, M.-V., Santos‐Medellín, C., González‐Valdez, A., Méndez, J.-L., Delgado, G., Morales-Espinosa, R., Servín‐González, L., Alcaraz, L. D., & Soberón‐Chávez, G. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-318 · Cited by 146
Synthesis of Gold Nanoparticles by Using Green Machinery: Characterization and In Vitro Toxicity
Saqr, A. A., Khafagy, E., Alalaiwe, A. S., Aldawsari, M. F., Alshahrani, S. M., Anwer, M. K., Khan, S., Lila, A. S. A., Arab, H. H., & Hegazy, W. A. H. (2021) · Nanomaterials · doi:10.3390/nano11030808 · Cited by 138
Recent developments for Pseudomonas vaccines
Sharma, A., Krause, A., & Worgall, S. (2011) · Human Vaccines · doi:10.4161/hv.7.10.16369 · Cited by 137
Current and future perspectives in the treatment of multidrug-resistant Gram-negative infections
Bassetti, M., & Garau, J. (2021) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkab352 · Cited by 136
Gutu, A. D., Sgambati, N., Strasbourger, P., Brannon, M. K., Jacobs, M. A., Haugen, E., Kaul, R., Johansen, H. K., Høiby, N., & Moskowitz, S. M. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02353-12 · Cited by 131
Sadovskaya, I., VINOGRADOV, E. V., Li, J., Hachani, A., Kowalska, K., & Filloux, A. (2010) · Glycobiology · doi:10.1093/glycob/cwq047 · Cited by 123
Phage steering of antibiotic-resistance evolution in the bacterial pathogen, Pseudomonas aeruginosa
Gurney, J., Pradier, L., Griffin, J. S., Gougat‐Barbera, C., Chan, B. K., Turner, P. E., Kaltz, O., & Hochberg, M. (2020) · Evolution Medicine and Public Health · doi:10.1093/emph/eoaa026 · Cited by 116
Strategies for the use of bacteriocins in Gram-negative bacteria: relevance in food microbiology
Prudêncio, C. V., dos Santos, M. T., & Vanetti, M. C. D. (2015) · Journal of Food Science and Technology · doi:10.1007/s13197-014-1666-2 · Cited by 115
Avakh, A., Grant, G. D., Cheesman, M. J., Kalkundri, T., & Hall, S. (2023) · Antibiotics · doi:10.3390/antibiotics12081304 · Cited by 111
Effect of Human Burn Wound Exudate on Pseudomonas aeruginosa Virulence
Gonzalez, M. R., Fleuchot, B., Lauciello, L., Jafari, P., Applegate, L. A., Raffoul, W., Que, Y.-A., & Perron, K. (2016) · mSphere · doi:10.1128/msphere.00111-15 · Cited by 109
Chastre, J., François, B., Bourgeois, M., Komnos, A., Ferrer, R., Rahav, G., De Schryver, N., Lepape, A., Koksal, I., Luyt, C.-E., et al. (2022) · Critical Care · doi:10.1186/s13054-022-04204-9 · Cited by 104
Bacteria in sputum of stable severe asthma and increased airway wall thickness
Zhang, Q., Illing, R. O., Hui, C., Downey, K., Carr, D. H., Stearn, M., Alshafi, K., Menzies-Gow, A. N., Zhong, N., & Chung, K. F. (2012) · Respiratory Research · doi:10.1186/1465-9921-13-35 · Cited by 103
Youns, M., & Hegazy, W. A. H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169335 · Cited by 103
Hernando‐Amado, S., Alcalde‐Rico, M., Gil‐Gil, T., Valverde, J. R., & Martínez, J. L. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00025 · Cited by 102
Sanya, D. R. A., Onésime, D., Vizzarro, G., & Jacquier, N. (2023) · BMC Microbiology · doi:10.1186/s12866-023-02832-x · Cited by 101
Lang, A. B., Rüdeberg, A., Schöni, M. H., Que, J. U., Fürer, E., & Schaad, U. B. (2004) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000129688.50588.ac · Cited by 99
Juan, C., Torrens, G., González-Nicolau, M., & Oliver, A. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux043 · Cited by 99
Pseudomonas aeruginosa tssC1 Links Type VI Secretion and Biofilm-Specific Antibiotic Resistance
Zhang, L., Hinz, A., Nadeau, J., & Mah, T. (2011) · Journal of Bacteriology · doi:10.1128/jb.00268-11 · Cited by 98
Schütz, C., & Empting, M. (2018) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.14.241 · Cited by 96
Controlling Biofilm Development Through Cyclic di-GMP Signaling
Park, S., & Sauer, K. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-08491-1_3 · Cited by 96
Kritsotakis, E. I., Kontopidou, F. V., Astrinaki, E., Roumbelaki, M., Ioannidou, E., & Gikas, A. I. (2017) · Infection and Drug Resistance · doi:10.2147/idr.s147459 · Cited by 94
Pseudomonas aeruginosa: Recent Advances in Vaccine Development
Killough, M., Rodgers, A., & Ingram, R. (2022) · Vaccines · doi:10.3390/vaccines10071100 · Cited by 93
Chan, K., Liu, Y., & Chang, C. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01173 · Cited by 91
Xiong, J., Alexander, D. C., Ma, J. H., Déraspe, M., Low, D. E., Jamieson, F., & Roy, P. H. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00423-13 · Cited by 86
Ropy, A., Cabot, G., Sánchez-Diener, I., Aguilera, C., Moyá, B., Ayala, J. A., & Oliver, A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05150-14 · Cited by 85
Structure and function of the porin channel
Welte, W., Nestel, U., Wacker, T., & Diederichs, K. (1995) · Kidney International · doi:10.1038/ki.1995.374 · Cited by 81
Yang, F., Gu, J., Yang, L., Chen, G., Jing, H., Wang, Y., Zeng, H., Zou, Q., Lv, F., & Zhang, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-04029-5 · Cited by 78
Patel, A. R., DiGiandomenico, A., Keller, A. E., Smith, T. R. F., Park, D. H., Ramos, S. J., Schultheis, K., Elliott, S. T. C., Mendoza, J. M., Broderick, K. E., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00576-7 · Cited by 78
Anti-Quorum Sensing Activities of Gliptins against Pseudomonas aeruginosa and Staphylococcus aureus
Khayat, M. T. A., Abbas, H. A., Ibrahim, T. S., Khayyat, A. N., Alharbi, M., Darwish, K. M., Elhady, S. S., Khafagy, E., Safo, M. K., & Hegazy, W. A. H. (2022) · Biomedicines · doi:10.3390/biomedicines10051169 · Cited by 73
Self-citationMishra, R., Kushveer, J. S., Khan, M. I. K., Pagal, S., Meena, C. K., Murali, A., Dhayalan, A., & Sarma, V. V. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01668 · Cited by 70
Valentin, J. D. P., Straub, H., Pietsch, F., Lemare, M., Ahrens, C. H., Schreiber, F., Webb, J. S., van der Mei, H. C., & Ren, Q. (2021) · The ISME Journal · doi:10.1038/s41396-021-01157-9 · Cited by 70
Lipase LipC affects motility, biofilm formation and rhamnolipid production in Pseudomonas aeruginosa
Rosenau, F., Isenhardt, S., Gdynia, A., Tielker, D., Schmidt, E., Tielen, P., Schobert, M., Jahn, D., Wilhelm, S., & Jaeger, K. (2010) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2010.02017.x · Cited by 68
Li, Y., Roberts, J. A., Walker, M. M., Aslan, A. T., Harris, P. N. A., & Sime, F. B. (2023) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2023.11.023 · Cited by 68
Pseudomonas aeruginosa bloodstream infections: how should we treat them?
van Delden, C. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.06.015 · Cited by 66
OprD mutations and inactivation in imipenem-resistant Pseudomonas aeruginosa isolates from China
Fang, Z.-L., Zhang, L., Huang, Y.-M., et al. (2013) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2013.10.027 · Cited by 61
Hafiz, T. A., Essa, E. A. B., Alharbi, S. R., Alyami, A. S., Alkudmani, Z. S., Mubaraki, M. A., Alturki, N. A., & Alotaibi, F. E. (2023) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed8040205 · Cited by 61
Current concepts on Pseudomonas aeruginosa interaction with human airway epithelium
Muggeo, A., Coraux, C., & Guillard, T. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011221 · Cited by 59
Cigana, C., Castandet, J., Sprynski, N., Melessike, M., Beyria, L., Ranucci, S., Alcalá-Franco, B., Rossi, A., Bragonzi, A., Zalacaín, M., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.620819 · Cited by 58
Bhardwaj, S., Bhatia, S., Singh, S., & Franco, F. C. (2021) · PubMed Central · doi:10.22038/ijbms.2021.49151.11254 · Cited by 54
Polymyxin Stereochemistry and Its Role in Antibacterial Activity and Outer Membrane Disruption
Slingerland, C. J., Kotsogianni, I., Wesseling, C. M. J., & Martin, N. I. (2022) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.2c00307 · Cited by 52
Elfadadny, A., Ragab, R. F., Hamada, R., Jaouni, S. K. A., Fu, J., Mousa, S. A., & El‐Far, A. H. (2023) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2023.116405 · Cited by 52
Self-citationInvasion and diversity in Pseudomonas aeruginosa urinary tract infections
Newman, J., Floyd, R., & Fothergill, J. (2022) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001458 · Cited by 51
The role of nanocomposites against biofilm infections in humans
Varma, A., Warghane, A. J., Dhiman, N. K., Paserkar, N., Upadhye, V. J., Modi, A., & Saini, R. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1104615 · Cited by 51
Exolysin Shapes the Virulence of Pseudomonas aeruginosa Clonal Outliers
Reboud, E., Basso, P., Maillard, A., Huber, P., & Attrée, I. (2017) · Toxins · doi:10.3390/toxins9110364 · Cited by 47
Choudhuri, A. H., Chakravarty, M., & Uppal, R. (2017) · Saudi Journal of Anaesthesia · doi:10.4103/sja.sja_230_17 · Cited by 43
Hardy, K. S., Tessmer, M. H., Frank, D. W., & Audia, J. P. (2021) · Toxins · doi:10.3390/toxins13120880 · Cited by 43
Membrane-Interactive Compounds From Pistacia lentiscus L. Thwart Pseudomonas aeruginosa Virulence
Tahrioui, A., Ortíz, S., Azuama, O. C., Bouffartigues, E., Benalia, N., Tortuel, D., Maillot, O., Chemat, S., Kritsanida, M., Feuilloley, M. G. J., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01068 · Cited by 42
Leroy, O., d’Escrivan, T., Devos, P., Dubreuil, L. J., Kipnis, É., & Georges, H. (2005) · Infection · doi:10.1007/s15010-005-4021-8 · Cited by 41
Madaha, E. L., Mienie, C. M. S., Gonsu, H. K., Bughe, R. N., Fonkoua, M. C., Mbacham, W. F., Alayande, K. A., Bezuidenhout, C. C., & Ateba, C. N. (2020) · PLoS ONE · doi:10.1371/journal.pone.0238390 · Cited by 40
Kanak, K. R., Dass, R. S., & Pan, A. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1203672 · Cited by 40
Foucrier, A., Dessalle, T., Tuffet, S., Federici, L., Dahyot‐Fizelier, C., Barbier, F., Pottecher, J., Monsel, A., Hissem, T., Lefrant, J., et al. (2023) · Critical Care · doi:10.1186/s13054-023-04457-y · Cited by 37
The Impact of the Virulence of Pseudomonas aeruginosa Isolated from Dogs
de Sousa, T., Garcês, A., Silva, A., Lopes, R., Alegria, N., Hébraud, M., Igrejas, G., & Poeta, P. A. C. Q. D. (2023) · Veterinary Sciences · doi:10.3390/vetsci10050343 · Cited by 36
Ma, C., Ma, X., Jiang, B.-G., Pan, H., Liao, X., Zhang, L., Li, W., Luo, Y., Shen, Z., Cheng, X., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00752-8 · Cited by 33
Tracking the phage trends: A comprehensive review of applications in therapy and food production
Jaglan, A. B., Anand, T., Verma, R., Vashisth, M., Virmani, N., Bera, B. C., Vaid, R. K., & Tripathi, B. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.993990 · Cited by 33
Mekonnen, S. A., Husseini, N. E., Turdiev, A., Carter, J. A., Belew, A. T., El-Sayed, N. M., & Lee, V. T. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2209383119 · Cited by 33
Pseudomonas aeruginosa Bloodstream Infections in SARS-CoV-2 Infected Patients: A Systematic Review
Bongiovanni, M., & Barda, B. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12062252 · Cited by 32
Elfadadny, A., Uchiyama, J., Goto, K., Imanishi, I., Ragab, R. F., Nageeb, W. M., Iyori, K., Toyoda, Y., Tsukui, T., Ide, K., et al. (2023) · Frontiers in Veterinary Science · doi:10.3389/fvets.2023.1074127 · Cited by 32
Self-citationBacteriophage can lyse antibiotic-resistant Pseudomonas aeruginosa isolated from canine diseases
Furusawa, T., Iwano, H., Higuchi, H., Yokota, H., Usui, M., Iwasaki, T., & Tamura, Y. (2016) · Journal of Veterinary Medical Science · doi:10.1292/jvms.15-0310 · Cited by 29
Fujiwara, M., Yamasaki, S., Morita, Y., & Nishino, K. (2022) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2022.01.003 · Cited by 29
Wang, T., Hou, Y., & Wang, R. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-3765-1 · Cited by 28
(AHAW), E. P. O. A. H. A. W., Nielsen, S. S., Bicout, D., Calistri, P., Canali, E., Drewe, J. A., Garin‐Bastuji, B., Gonzáles, J. L., Gortázar, C., Herskin, M. S., et al. (2022) · EFSA Journal · doi:10.2903/j.efsa.2022.7311 · Cited by 27
Briers, Y. (2019) · Viruses · doi:10.3390/v11020113 · Cited by 26
Genetic and environmental determinants of surface adaptations in Pseudomonas aeruginosa
Ambreetha, S., & Singh, V. (2023) · Microbiology · doi:10.1099/mic.0.001335 · Cited by 23
Recent Advances in Combating Bacterial Infections by Using Hybrid Nano-Systems
Patel, U., & Hunt, E. C. (2023) · Journal of Nanotheranostics · doi:10.3390/jnt4030019 · Cited by 21
Pseudomonas aeruginosa Activates PKC-Alpha to Invade Middle Ear Epithelial Cells
Mittal, R., Grati, M., Yan, D. L. S., & Liu, X. Z. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00255 · Cited by 20
Sun, P., Won, J., Choo-Kang, G., Li, S., Chen, W., Monroy, G. L., Chaney, E. J., Boppart, S. A., Eden, J. G., & Nguyen, T. H. (2021) · npj Biofilms and Microbiomes · doi:10.1038/s41522-021-00219-2 · Cited by 19
Phage derived lytic peptides, a secret weapon against Acinetobacter baumannii—An in silico approach
Nandy, A., Yadav, R., & Singh, A. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1047752 · Cited by 19
Trends of 9,416 multidrug-resistant Gram-negative bacteria
Oliveira, V. D. C., Rubio, F. G., de Almeida, M. T. G., Nogueira, M. C. L., & Pignatari, A. C. C. (2015) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.61.03.244 · Cited by 18
Karam, M. R. A., Badmasti, F., Ahmadi, K., & Habibi, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-05157-3 · Cited by 16
Wusiman, A., Zhang, Y., Ayihengbieke, T., Cheng, X., Kudereti, T., Liu, D., Wang, D., & Abula, S. (2022) · Poultry Science · doi:10.1016/j.psj.2022.101791 · Cited by 16
Sadaqat, M. H., Mobarez, A. M., & Nikkhah, M. (2022) · Microbial Pathogenesis · doi:10.1016/j.micpath.2022.105860 · Cited by 15
Treatment Heterogeneity in Pseudomonas aeruginosa Pneumonia
Caffrey, A. R., Appaneal, H. J., Liao, J. X., Piehl, E. C., Lopes, V., & Puzniak, L. (2022) · Antibiotics · doi:10.3390/antibiotics11081033 · Cited by 10
dos Santos, P. A. S., Rodrigues, Y. C., Marcon, D. J., Lobato, A. R. F., Cazuza, T. B., Gouveia, M. I. M., Silva, M. J. A., Souza, A. B., Lima, L. N. G. C., Quaresma, A. J. P. G., et al. (2023) · Microorganisms · doi:10.3390/microorganisms11082069 · Cited by 10
Pyoverdine as an Important Virulence Factor in Pseudomonas aeruginosa Antibiotic Resistance
Durán, O., Ramos, C. W., Chen, O., Castillo, J., de Mayorga, B., & de Chial, M. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.104222 · Cited by 9
Pseudomonas aeruginosa: The Alarming Pathogen of Hospital Acquired Infection
Farzin, A., Rahman, M. M., & Mollika, F. A. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.110249 · Cited by 9
Preparation and characterization of Meta-bromo-thiolactone calcium alginate nanoparticles
Eltayb, E. K., Aleanizy, F. S., Alqahtani, F. Y., Alkahtani, H. M., Ansari, S. A., & Alsarra, I. A. (2022) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2022.05.008 · Cited by 7
Metadata
- Authors
- Elfadadny, A., Ragab, R. F., AlHarbi, M., Badshah, F., Ibáñez-Arancibia, E., Farag, A., Hendawy, A. O., De los Ríos-Escalante, P. R., Aboubakr, M., Zakai, S. A., & Nageeb, W. M.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2024-04-05
- Volume
- 15
- Pages
- 1374466-1374466
- ISSN
- 1664-302X (ISSN-L)
- OpenAlex
- W4393984276
- Cited by
- 340
- References
- 151
- FWCI
- 39.39
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.